Literature DB >> 11773103

Prevalence of antibodies to hepatitis E virus in veterinarians working with swine and in normal blood donors in the United States and other countries.

X J Meng1, B Wiseman, F Elvinger, D K Guenette, T E Toth, R E Engle, S U Emerson, R H Purcell.   

Abstract

Hepatitis E virus (HEV) is endemic in many developing and some industrialized countries. It has been hypothesized that animals may be the source of infection. The recent identification of swine HEV in U.S. pigs and the demonstration of its ability to infect across species have lent credence to this hypothesis. To assess the potential risk of zoonotic HEV infection, we tested a total of 468 veterinarians working with swine (including 389 U.S. swine veterinarians) and 400 normal U.S. blood donors for immunoglobulin G anti-HEV. Recombinant capsid antigens from a U.S. strain of swine HEV and from a human HEV strain (Sar-55) were each used in an enzyme-linked immunosorbent assay. The anti-HEV prevalence assayed with the swine HEV antigen showed 97% concordance with that obtained with the human HEV antigen (kappa = 92%). Among the 295 swine veterinarians tested from the eight U.S. states (Minnesota, Indiana, Nebraska, Iowa, Illinois, Missouri, North Carolina, and Alabama) from which normal blood donor samples were available, 26% were positive with Sar-55 antigen and 23% were positive with swine HEV antigen. In contrast, 18% of the blood donors from the same eight U.S. states were positive with Sar-55 antigen and 17% were positive with swine HEV antigen. Swine veterinarians in the eight states were 1.51 times more likely when tested with swine HEV antigen (95% confidence interval, 1.03 to 2.20) and 1.46 times more likely when tested with Sar-55 antigen (95% confidence interval, 0.99 to 2.17) to be anti-HEV positive than normal blood donors. We did not find a difference in anti-HEV prevalence between veterinarians who reported having had a needle stick or cut and those who had not or between those who spent more time (> or = 80% of the time) and those who spent less time (< or = 20% of the time) working with pigs. Similarly, we did not find a difference in anti-HEV prevalence according to four job categories (academic, practicing, student, and industry veterinarians). There was a difference in anti-HEV prevalence in both swine veterinarians and blood donors among the eight selected states, with subjects from Minnesota six times more likely to be anti-HEV positive than those from Alabama. Age was not a factor in the observed differences from state to state. Anti-HEV prevalence in swine veterinarians and normal blood donors was age specific and paralleled increasing age. The results suggest that swine veterinarians may be at somewhat higher risk of HEV infection than are normal blood donors.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11773103      PMCID: PMC120098          DOI: 10.1128/JCM.40.1.117-122.2002

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  41 in total

1.  Severe hepatitis E infection during pregnancy.

Authors:  S H Hussaini; S J Skidmore; P Richardson; L M Sherratt; B T Cooper; J G O'Grady
Journal:  J Viral Hepat       Date:  1997-01       Impact factor: 3.728

2.  Prevalence of and risk factors for antibody to hepatitis E virus seroreactivity among blood donors in Northern California.

Authors:  E E Mast; I K Kuramoto; M O Favorov; V R Schoening; B T Burkholder; C N Shapiro; P V Holland
Journal:  J Infect Dis       Date:  1997-07       Impact factor: 5.226

3.  Seroreactivity to hepatitis E virus in areas where the disease is not endemic.

Authors:  D L Thomas; P O Yarbough; D Vlahov; S A Tsarev; K E Nelson; A J Saah; R H Purcell
Journal:  J Clin Microbiol       Date:  1997-05       Impact factor: 5.948

4.  Experimental infection of the laboratory rat with the hepatitis E virus.

Authors:  Y Maneerat; E T Clayson; K S Myint; G D Young; B L Innis
Journal:  J Med Virol       Date:  1996-02       Impact factor: 2.327

5.  Fulminant hepatic failure in pregnant women: acute fatty liver or acute viral hepatitis?

Authors:  S S Hamid; S M Jafri; H Khan; H Shah; Z Abbas; H Fields
Journal:  J Hepatol       Date:  1996-07       Impact factor: 25.083

6.  Seroepidemiology of water-borne hepatitis in India and evidence for a third enterically-transmitted hepatitis agent.

Authors:  V A Arankalle; M S Chadha; S A Tsarev; S U Emerson; A R Risbud; K Banerjee; R H Purcell
Journal:  Proc Natl Acad Sci U S A       Date:  1994-04-12       Impact factor: 11.205

7.  Detection of hepatitis E virus infections among domestic swine in the Kathmandu Valley of Nepal.

Authors:  E T Clayson; B L Innis; K S Myint; S Narupiti; D W Vaughn; S Giri; P Ranabhat; M P Shrestha
Journal:  Am J Trop Med Hyg       Date:  1995-09       Impact factor: 2.345

8.  Antibodies against hepatitis E virus in Old World monkeys.

Authors:  V A Arankalle; M K Goverdhan; K Banerjee
Journal:  J Viral Hepat       Date:  1994       Impact factor: 3.728

9.  Experimental hepatitis E in pregnant rhesus monkeys: failure to transmit hepatitis E virus (HEV) to offspring and evidence of naturally acquired antibodies to HEV.

Authors:  S A Tsarev; T S Tsareva; S U Emerson; M K Rippy; P Zack; M Shapiro; R H Purcell
Journal:  J Infect Dis       Date:  1995-07       Impact factor: 5.226

10.  Hepatitis type E in Italy: a seroepidemiological survey. Study Group of Hepatitis E.

Authors:  A R Zanetti; G J Dawson
Journal:  J Med Virol       Date:  1994-03       Impact factor: 2.327

View more
  146 in total

1.  [Rare acute hepatitis in a female patient with hemochromatosis: a zoonosis?].

Authors:  Stephan Vetter; Dirk Hartmann; Ralf Jakobs; Jürgen F Riemann
Journal:  Med Klin (Munich)       Date:  2010-04

2.  Hepatitis E Virus.

Authors: 
Journal:  Transfus Med Hemother       Date:  2009       Impact factor: 3.747

3.  Characterization of hepatitis E virus recombinant ORF2 proteins expressed by vaccinia viruses.

Authors:  Nereida Jiménez de Oya; Estela Escribano-Romero; Ana-Belén Blázquez; María Lorenzo; Miguel A Martín-Acebes; Rafael Blasco; Juan-Carlos Saiz
Journal:  J Virol       Date:  2012-05-16       Impact factor: 5.103

4.  Clinical and epidemiological aspects of a hepatitis E outbreak in Bangui, Central African Republic.

Authors:  Alice I Goumba; Xavier Konamna; Narcisse P Komas
Journal:  BMC Infect Dis       Date:  2011-04-14       Impact factor: 3.090

5.  Initiation at the third in-frame AUG codon of open reading frame 3 of the hepatitis E virus is essential for viral infectivity in vivo.

Authors:  Y W Huang; T Opriessnig; P G Halbur; X J Meng
Journal:  J Virol       Date:  2007-01-03       Impact factor: 5.103

6.  The Enigma of Hepatitis E Virus.

Authors:  Liza Bronner Murrison; Kenneth E Sherman
Journal:  Gastroenterol Hepatol (N Y)       Date:  2017-08

Review 7.  Chronic hepatitis E: A brief review.

Authors:  Arvind R Murali; Vikram Kotwal; Saurabh Chawla
Journal:  World J Hepatol       Date:  2015-09-08

8.  Bayesian estimation of hepatitis E virus seroprevalence for populations with different exposure levels to swine in The Netherlands.

Authors:  M Bouwknegt; B Engel; M M P T Herremans; M A Widdowson; H C Worm; M P G Koopmans; K Frankena; A M de Roda Husman; M C M De Jong; W H M Van Der Poel
Journal:  Epidemiol Infect       Date:  2007-06-20       Impact factor: 2.451

9.  Probable transmission of hepatitis E virus (HEV) via transfusion in the United States.

Authors:  John R Ticehurst; Nora Pisanic; Michael S Forman; Carly Ordak; Christopher D Heaney; Edgar Ong; Jeffrey M Linnen; Paul M Ness; Nan Guo; Hua Shan; Kenrad E Nelson
Journal:  Transfusion       Date:  2019-01-31       Impact factor: 3.157

10.  Polyphyletic strains of hepatitis E virus are responsible for sporadic cases of acute hepatitis in Japan.

Authors:  Hitoshi Mizuo; Kazuyuki Suzuki; Yasuhiro Takikawa; Yoshiki Sugai; Hajime Tokita; Yoshihiro Akahane; Keiichi Itoh; Yuhko Gotanda; Masaharu Takahashi; Tsutomu Nishizawa; Hiroaki Okamoto
Journal:  J Clin Microbiol       Date:  2002-09       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.